Significant decrease in in-hospital mortality and major adverse cardiac events in Swiss STEMI patients between 2000
Valérie Stolt Steiger1, Jean-Jacques Goy, Jean-Christophe Stauffer
1Division of Cardiology, Hôpital Cantonal, Fribourg, Switzerland. valerie.stolt@turnover.ch
Swiss Medical Weekly
|August 18, 2009
Summary
In-hospital mortality and reinfarction rates for ST elevation myocardial infarction (STEMI) patients in Switzerland significantly decreased between 2000 and 2007. This improvement is strongly linked to increased access to percutaneous coronary interventions (PCI).
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- ST elevation myocardial infarction (STEMI) remains a critical cardiovascular condition requiring effective in-hospital management.
- Understanding trends in STEMI outcomes and identifying key predictors is crucial for improving patient care.
- The period 2000-2007 saw significant advancements in cardiovascular interventions, particularly percutaneous coronary intervention (PCI).
Purpose of the Study:
- To evaluate the in-hospital outcomes for STEMI patients in Switzerland from 2000 to 2007.
- To identify predictors of in-hospital mortality and major adverse cardiac events in this patient cohort.
- To assess the impact of evolving treatment strategies, such as PCI, on STEMI outcomes.
Main Methods:
- Analysis of data from the Swiss national registry AMIS Plus (Acute Myocardial Infarction and Unstable Angina in Switzerland).
- Inclusion of 12,026 patients diagnosed with STEMI or new left bundle branch block (LBBB) between January 2000 and December 2007.
- Statistical evaluation of in-hospital mortality, reinfarction rates, and treatment modalities, including PCI and thrombolysis.
Main Results:
- In-hospital mortality decreased from 7.6% in 2000 to 6% in 2007; reinfarction rates fell from 3.7% to 0.9%.
- Percutaneous coronary intervention (PCI) use increased from 43% to 85%, with PCI patients exhibiting significantly lower mortality (3.9% vs. 11.2%) and reinfarction rates (1.1% vs. 3.1%).
- Key predictors of mortality included older age (>65), Killip class III/IV, diabetes, and Q-wave myocardial infarction; PCI access was the strongest predictor of survival.
Conclusions:
- Significant reductions in in-hospital mortality and reinfarction were observed in Swiss STEMI patients over a seven-year period.
- The increase in percutaneous coronary interventions (PCI) alongside medical therapy was strongly associated with these improved outcomes.
- Access to PCI facilities, rather than the specific hospital of admission, emerged as a critical determinant of patient survival.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...